2 recruiting, 1 active not recruiting, 1 completed, 1 suspended. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Recruiting 2, Active not recruiting 1, Completed 1, Suspended 1, Withdrawn 1 |
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Suspended 1 |
Follow Refractory Grade 3b Follicular Lymphoma: new trials by email Literature Review of Refractory Grade 3b Follicular Lymphoma trials Research Report on Refractory Grade 3b Follicular Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma Vevoctadekin, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 1 / Phase 2 | Suspended | Fred Hutchinson Cancer Center | 33 | 2025-12-27 | 2026-09-11 |
| Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 3b Follicular Lymphoma | Phase 1 / Phase 2 | Recruiting | Yazeed Sawalha | 38 | 2025-04-02 | 2026-08-25 |
| Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine - AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma | Phase 1 | Recruiting | AIDS Malignancy Consortium | 20 | 2025-02-13 | 2026-07-10 |
| NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Cyclophosphamide, Fludarabine, Lisocabtagene Maraleucel - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 1 | Completed | Fred Hutchinson Cancer Center | 27 | 2022-12-08 | 2026-09-21 |
| ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma CD47 Antagonist ALX148, Lenalidomide, Rituximab - Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 47 | 2021-10-13 | 2026-09-18 |
| CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL CpG-STAT3 siRNA CAS3/SS3, Radiation Therapy - Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma | Phase 1 | Withdrawn | City of Hope Medical Center | 2021-07-27 | 2024-04-25 |
Lymphoma, Large B-Cell, Diffuse (5) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Mantle-Cell (2) · Composite Lymphoma (1) · HIV Infections (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1)
Hemic and Lymphatic Diseases (6) · Immune System Diseases (6) · Immunoproliferative Disorders (6) · Lymphatic Diseases (6) · Lymphoma (6) · Lymphoproliferative Disorders (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Lymphoma, B-Cell (5) · Lymphoma, Non-Hodgkin (5) · Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · Disease Attributes (1) · Genital Diseases (1)
Biopsy (3) · Magnetic Resonance Spectroscopy (3) · Cyclophosphamide (2) · Phantoms, Imaging (2) · Spinal Puncture (2) · X-Rays (2) · fludarabine (2) · ALX148 (1) · CPG-oligonucleotide (1) · CT-P10 (1) · Lenalidomide (1) · Leukapheresis (1) · NKTR-255 (1) · Radiation (1) · Radiotherapy (1)
Fred Hutchinson Cancer Center (2) · AIDS Malignancy Consortium (1) · City of Hope Medical Center (1) · M.D. Anderson Cancer Center (1) · Yazeed Sawalha (1)
United States (5)
Alexandre Hirayama (1) · Alexandre V. Hirayama, MD (1) · Ariela Noy (1) · Lihua E Budde (1) · Paolo Strati, MD (1) · Yazeed Sawalha (1)
P30CA033572 (1), P50CA107399 (1), UM1CA121947 (1)